During the meeting, our research-project and work-package leads will discuss how HARMONY is addressing a number of important research questions in Hematologic Malignancies.
Meeting points:
Click here view the agenda, indicating details of the HARMONY presentations that will be taking place.
ELN is a publicly funded research network of excellence, with a goal of improving the treatment of leukemia through the collaboration of research efforts across Europe. Click here to visit the official ELN website.
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Read about our ongoing and upcoming research projects.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
